The Intergroup Rhabdomyosarcoma Study II: objectives and study design.
D002648:Child; D003609:Dactinomycin / Q000627:therapeutic use; D006801:Humans; D012106:Research; D012107:Research Design; D012208:Rhabdomyosarcoma / Q000188:drug therapy; D014750:Vincristine / Q000627:therapeutic use
D003609:Dactinomycin; D014750:Vincristine